| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/19/2009 | US20090076020 Cyclopropyl Amide Derivatives 978 |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090076006 Hsp90 inhibitors containing a zinc binding moiety |
| 03/19/2009 | US20090076004 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075980 Pyrazolopyridines and Analogs Thereof |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090074890 Substituted Triazoles as Sodium Channel Blockers |
| 03/19/2009 | US20090074825 Colorants based n-halamines compositions and method of making and using |
| 03/19/2009 | US20090074791 Phenylisoquinoline and Phenylquinazoline Derivatives |
| 03/19/2009 | US20090074373 Optical filter |
| 03/19/2009 | CA2699384A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/19/2009 | CA2699383A1 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists |
| 03/19/2009 | CA2699038A1 Phthalazinone derivatives |
| 03/19/2009 | CA2698792A1 Vegfr inhibitors containing a zinc binding moiety |
| 03/18/2009 | EP2036903A1 Potentiator of radiation therapy |
| 03/18/2009 | EP2036896A1 Cyclic amine compound |
| 03/18/2009 | EP2036894A1 Aurora inhibitor |
| 03/18/2009 | EP2036893A1 Abl KINASE INHIBITOR |
| 03/18/2009 | EP2036889A2 Substituted indoles and a method for the production and use thereof |
| 03/18/2009 | EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor |
| 03/18/2009 | EP2035408A1 Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 03/18/2009 | EP2035407A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 03/18/2009 | EP2035396A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2035395A2 Novel processes for the preparation of dpp iv inhibitors |
| 03/18/2009 | EP2035394A1 2-pyrazinecarboxamide derivatives |
| 03/18/2009 | EP2035391A1 Indazole derivatives for treating hsp90-induced diseases |
| 03/18/2009 | EP2035379A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/18/2009 | EP2035378A1 Substituted isoindoles as bace inhibitors and their use |
| 03/18/2009 | EP2035376A1 Indoline amide derivatives as ep4 receptor ligands |
| 03/18/2009 | EP2035375A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 03/18/2009 | EP2035372A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 03/18/2009 | EP2035371A2 Substituted phenyl methanone derivatives |
| 03/18/2009 | EP2034996A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2034994A2 Nf-kappa b inhibitors and uses thereof |
| 03/18/2009 | EP2034993A2 Pyrazinones as cellular proliferation inhibitors |
| 03/18/2009 | EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
| 03/18/2009 | EP1581262B1 Contrast agent |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | CN101389331A Amino acid derivatives of indolinone based protein kinase inhibitors |
| 03/18/2009 | CN101386618A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 03/18/2009 | CN101386602A S-triazine derivates with white light and preparation method and application thereof |
| 03/18/2009 | CN100469779C Inhibitors of interleukin-1beta converting enzyme |
| 03/17/2009 | US7504516 Crystalline forms of candesartan cilexetil |
| 03/17/2009 | US7504503 Process for producing substituted aniline compound |
| 03/17/2009 | US7504501 Antiprotozoal imidazopyridine compounds |
| 03/17/2009 | US7504500 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 03/17/2009 | US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/17/2009 | US7504426 Antiallergens; rhitinis; antiinflammatory agents |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/17/2009 | US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
| 03/17/2009 | US7504402 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 03/17/2009 | US7504401 Anti-cancer agents and uses thereof |
| 03/17/2009 | US7504400 MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles |
| 03/17/2009 | US7504396 Substituted heterocyclic compounds and methods of use |
| 03/17/2009 | US7504394 Bazedoxifene ascorbate |
| 03/17/2009 | US7504391 Analogues of N-methyl, hydroxy(alkoxy)-partially saturated indeno(1,2-a)-3-benzoazeines, naphtho(1,2-a)-3-benzoazepines, and 1-phenyl-3-benzazepenes; metabolic disorders/eating disorders, e.g., obesity (dietetics), hyperphagia; antidiabetic agents; obsessive compulsive, somatoform dissociative disorders |
| 03/17/2009 | US7504362 Pesticidal compositions |
| 03/17/2009 | US7504162 Heat resistance; forming film |
| 03/17/2009 | US7504089 Cyanine dyes |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/12/2009 | WO2009032703A1 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors |
| 03/12/2009 | WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 03/12/2009 | WO2009032277A1 Gamma secretase modulators |
| 03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
| 03/12/2009 | WO2009032198A1 Co-crystals and pharmaceutical compositions comprising the same |
| 03/12/2009 | WO2009032124A1 Substituted indole derivatives and methods of use thereof |
| 03/12/2009 | WO2009030316A1 1,3-dihydroisoindole derivatives |
| 03/12/2009 | WO2009030270A1 Dihydroindole derivatives useful in parkinson's disease |
| 03/12/2009 | WO2009010139A3 Quinazolinamide derivatives |
| 03/12/2009 | WO2008155668A3 Heteroarylamide pyrimidone compounds |
| 03/12/2009 | WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists |
| 03/12/2009 | US20090069565 New indole derivatives as factor xa inhibitors |
| 03/12/2009 | US20090069561 Click chemistry route to triazole dendrimers |
| 03/12/2009 | US20090069546 Pyrazole-based cyanine dye |
| 03/12/2009 | US20090069470 Process for the synthesis of n-alkoxyamines |
| 03/12/2009 | US20090069351 Deuterium-enriched bosentan |
| 03/12/2009 | US20090069342 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents; 1-(aminosulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(3,4-dimethylphenyl)-2-imidazolidinone |
| 03/12/2009 | US20090069341 Inhibitors of hsp90 |
| 03/12/2009 | US20090069340 Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders |
| 03/12/2009 | US20090069334 Pyridazine based alpha-helix mimetics |
| 03/12/2009 | US20090069328 Alpha-alkyl substituted n-acyltryptophanols |
| 03/12/2009 | US20090069327 Compounds and compositions as protein kinase inhibitors |
| 03/12/2009 | US20090069326 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders |
| 03/12/2009 | US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections |
| 03/12/2009 | US20090069310 Anti-inflammatory medicaments |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069300 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/12/2009 | US20090069298 Pyrazolo[1,5-A]Pyrimidine Compounds |
| 03/12/2009 | US20090069297 protein kinase inhibnitors such as N-(4-((7-(methyloxy)-1,5-naphthyridin-4-yl)oxy)phenyl)-4-phenyl-1-phthalazinamine, for influencing the process of cell cycle and cell proliferation to treat cancer; anticarcinogenic agents |
| 03/12/2009 | US20090069288 Novel therapeutic compounds |
| 03/12/2009 | US20090069287 Substituted azacycloalkanes useful for treating cns conditions |
| 03/12/2009 | US20090069284 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
| 03/12/2009 | US20090069245 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |